浏览全部资源
扫码关注微信
1.武汉市第一医院药学部,武汉 430022
2.武汉市第一医院血管外科,武汉 430022
Published:29 February 2024,
Received:17 July 2023,
Revised:31 December 2023,
扫 描 看 全 文
江书正,陈熙,陈飞宇等.基于患者疾病自我管理能力的下肢动脉疾病药学服务模式的构建 Δ[J].中国药房,2024,35(04):500-505.
JIANG Shuzheng,CHEN Xi,CHEN Feiyu,et al.Establishment of pharmaceutical care model for lower extremity artery disease based on patients’ disease self-management ability[J].ZHONGGUO YAOFANG,2024,35(04):500-505.
江书正,陈熙,陈飞宇等.基于患者疾病自我管理能力的下肢动脉疾病药学服务模式的构建 Δ[J].中国药房,2024,35(04):500-505. DOI: 10.6039/j.issn.1001-0408.2024.04.22.
JIANG Shuzheng,CHEN Xi,CHEN Feiyu,et al.Establishment of pharmaceutical care model for lower extremity artery disease based on patients’ disease self-management ability[J].ZHONGGUO YAOFANG,2024,35(04):500-505. DOI: 10.6039/j.issn.1001-0408.2024.04.22.
目的
2
构建下肢动脉疾病(LEAD)患者院内药学监护+院外药学门诊一体化服务模式,提高患者的疾病自我管理能力及疾病治疗的有效性和安全性。
方法
2
构建LEAD患者院内药学监护及院外药学门诊服务模式(包含药学评估、自我管理能力宣教、药学随访),对患者进行长期管理。选取2021年9月-2022年12月在我院血管外科住院或门诊就诊并经药师管理的65例LEAD患者为研究对象,由药师进行院内药学监护+院外门诊持续管理,比较经药师管理3个月前后疾病治疗有效性指标、安全性指标和患者疾病自我管理能力指标。
结果
2
65例患者经药师管理3个月后,55例患者Fontaine分期降低,管理前后Fontaine分期差异有统计学意义(
P
<0.001);完全遵循指南用药的患者占比由63.1%提升至96.9%,小出血发生率减少7.7%,患者Morisky用药依从性评分和疾病自我管理能力评分显著提高(
P
<0.001),就医满意度为“好”的患者占比增加了18.4%。
结论
2
LEAD患者院内外一体化药学服务模式可有效提高患者疾病自我管理能力,提高患者疾病治疗的有效性及安全性。
OBJECTIVE
2
To construct the integrated pharmaceutical care model of in-hospital pharmaceutical care+out-hospital pharmacy outpatient service for patients with lower extremity artery disease (LEAD), so as to improve patients’ disease self-management ability, and the efficacy and safety of therapy.
METHODS
2
The in-hospital pharmaceutical care and out-hospital pharmacy outpatient service model was constructed for LEAD patients, including pharmaceutical evaluation, self-management ability education, and pharmacy follow-up, to perform long-term management of patients. Totally 65 LEAD patients admitted to the vascular surgery department of our hospital, receiving pharmacist management, from September, 2021 to December, 2022 were selected as the study objects, and pharmacists conducted in-hospital pharmaceutical care+continuous out-patient management. The efficacy indicators, safety indicators, and patients’s disease self-management ability indicators were compared before and after 3 months of pharmacist management.
RESULTS
2
After 3 months of pharmacists’ participation in the management of 65 patients, Fontaine stage decreased in 55 patients, there was the significant difference in Fontaine stage before and after management (
P
<0.001). The proportion of patients who completely followed the guidelines for medication increased from 63.1% to 96.9%; the incidence of small bleeding was reduced by 7.7% after pharmacists’ management. The scores of Morisky medication compliance and patients’ disease self-management ability were higher than 3 months ago (
P
<0.001). Patient proportion with “good” medical satisfaction increased by 18.4%.
CONCLUSIONS
2
The in-hospital pharmaceutical care and out-hospital pharmacy outpatient service model of LEAD patients can effectively improve patients’ disease self-management ability, and improve the efficacy and safety of therapy.
下肢动脉疾病疾病自我管理能力药学服务药学门诊
disease self-management abilitypharmaceutical carepharmaceutical clinic
WANG Z W,WANG X,HAO G,et al. A national study of the prevalence and risk factors associated with peripheral arterial disease from China:the China hypertension survey,2012-2015[J]. Int J Cardiol,2019,275:165-170.
RUDAN D A,RUDAN I,et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010:a systematic review and analysis[J]. Lancet,2013,382(9901):1329-1340.
下肢动脉粥样硬化性疾病诊治中国专家建议写作组,中华医学会老年医学分会,中华医学会心血管病学分会,等. 下肢动脉粥样硬化性疾病诊治中国专家建议:2007[J]. 中华老年医学杂志,2007,26(10):725-740.
Lower Extremity Atherosclerotic Disease Chinese Expert Recommendation Writing Group,Chinese Society of Geria- trics,Chinese Society of Cardiovascular Disease,et al. The recommendations of the diagnosis and management for the patients with lower extremity atherosclerotic disease:2007[J]. Chin J Geriatr,2007,26(10):725-740.
LAXY M,MIELCK A,HUNGER M,et al. The association between patient-reported self-management behavior,intermediate clinical outcomes,and mortality in patients with type 2 diabetes:results from the KORA:a study[J]. Diabetes Care,2014,37(6):1604-1612.
JOVICIC A,HOLROYD-LEDUC J M,STRAUS S E. Effects of self-management intervention on health outcomes of patients with heart failure:a systematic review of randomized controlled trials[J]. BMC Cardiovasc Disord,2006,6:43.
ALHABIB S,ALDRAIMLY M,ALFARHAN A. An evolving role of clinical pharmacists in managing diabetes:evidence from the literature[J]. Saudi Pharm J,2016,24(4):441-446.
WANG J X,WANG J,QIU S C,et al. Pharmaceutical care program for ischemic stroke patients:a randomized controlled trial[J]. Int J Clin Pharm,2021,43(5):1412-1419.
ÖSTBRING M J,ERIKSSON T,PETERSSON G,et al. Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease:the MIMeRiC randomized controlled trial[J]. BMC Cardiovasc Disord,2021,21(1):367.
朱梦春,杨玉金,郑春艳,等. 下肢动脉硬化闭塞症病人自我管理能力的研究进展[J]. 护理研究,2020,34(22):4019-4024.
ZHU M C,YANG Y J,ZHENG C Y,et al. Research pro-gress on self-management ability of patients with lower extremity arteriosclerosis obliterans[J]. Chin Nurs Res,2020,34(22):4019-4024.
CORBIN J,STRAUSS A. Unending work and care:ma- naging chronic illness at home[M]. San Francisco:Jossey-Bass,1988:945.
中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南[J]. 中华普通外科学文献(电子版),2016,10(1):1-18.
Vascular Surgery Group of the Chinese Medical Association Surgery Branch.Guidelines for diagnosis and treatment of arteriosclerosis obliterans of lower limbs[J]. Chin Arch Gen Surg Electron Ed,2016,10(1):1-18.
KAATZ S,AHMAD D,SPYROPOULOS A C,et al. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous throm- boembolic disease in non-surgical patients:communication from the SSC of the ISTH[J]. J Thromb Haemost,2015,13(11):2119-2126.
CHEN Q C,LI L L,CHEN Q G,et al. Critical appraisal of international guidelines for the screening and treatment of asymptomatic peripheral artery disease:a systematic review[J]. BMC Cardiovasc Disord,2019,19(1):17.
HIGASHI Y,MIYATA T,SHIGEMATSU H,et al. Two-year follow-up of vascular events in peripheral arterial disease treated with antiplatelet agents:a prospective observational multicenter cohort study:SEASON[J]. Sci Rep,2017,7(1):6095.
李赟,王立新,郭阳,等. 药师参与多学科诊疗的模式探讨及效果评价[J]. 中国药房,2023,34(12):1515-1519.
LI Y,WANG L X,GUO Y,et al. Investigation of the mode of pharmacist participating in multi-disciplinary diagnosis and treatment and effect evaluation[J]. China Pharm,2023,34(12):1515-1519.
HEIKKILA K,MITCHELL D C,LOFTUS I M,et al. Improving 1-year outcomes of infrainguinal limb revasculari-zation:population-based cohort study of 104 000 patients in England[J]. Circulation,2018,137(18):1921-1933.
PARVAR S L,NGO L,DAWSON J,et al. Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease:a propensity score-matched analysis[J]. Eur Heart J,2021,43(1):32-40.
KIM S Y,LEE Y M,SON Y J. Factors associated with self-management after hybrid revascularization in patients with peripheral artery disease:a structural equations model[J]. J Adv Nurs,2023,79(1):170-181.
0
Views
4
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution